Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations.

MLA

Aramburu, Ander, et al. “Combined Clinical and Genomic Signatures for the Prognosis of Early Stage Non-Small Cell Lung Cancer Based on Gene Copy Number Alterations.” BMC Genomics, vol. 16, Oct. 2015, p. 752. EBSCOhost, https://doi.org/10.1186/s12864-015-1935-0.

APA

Aramburu, A., Zudaire, I., Pajares, M. J., Agorreta, J., Orta, A., Lozano, M. D., Gúrpide, A., Gómez-Román, J., Martinez-Climent, J. A., Jassem, J., Skrzypski, M., Suraokar, M., Behrens, C., Wistuba, I. I., Pio, R., Rubio, A., & Montuenga, L. M. (2015). Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations. BMC Genomics, 16, 752. https://doi.org/10.1186/s12864-015-1935-0

Chicago

Aramburu, Ander, Isabel Zudaire, María J Pajares, Jackeline Agorreta, Alberto Orta, María D Lozano, Alfonso Gúrpide, et al. 2015. “Combined Clinical and Genomic Signatures for the Prognosis of Early Stage Non-Small Cell Lung Cancer Based on Gene Copy Number Alterations.” BMC Genomics 16 (October): 752. doi:10.1186/s12864-015-1935-0.